# Nuvectis Pharma, Inc.: Form DEF 14A, filed Apr 27, 2026

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: DEF 14A
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 16:37 ET
- Period: 2026-06-11
- Accession: 0001104659-26-049476
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465926049476/tm261542-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465926049476/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465926049476/tm261542-1_def14a.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-049476. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.